A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn shrinking health budgets may limit access in high-risk areas.

The United States has given its approval to the world’s first twice-a-year injection for HIV prevention, marking a ...

These four BofA Securities Growth 10 stocks come with reliable dividends and are are timely ideas for growth and income ...

He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...

According to the hospital’s management, the surgical camp will now become an annual fixture aimed at giving underserved communities a chance at receiving safe, affordable, and timely surgical care.

According to Otai, the people of Bukedea have been misled to believe in non-existent progress. She criticized the recently ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

Total solar eclipses are not just incredible celestial events. They are also important scientific moments that allow ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

While Gilead Sciences' HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made- ...

The Food and Drug Administration approved a new vaccine to prevent HIV infection, lenacapavir, a long-acting injection, which ...